AI Airlock programme
Benefits
Provides a controlled environment to trial AI tools safely, ensure their effectiveness, identify limitations and challenges around the use of AI as a medical device, and explore potential pathways towards regulatory approval. The programme helps accelerate safe AI innovation and supports the Government's vision for the NHS to be the world's most AI-enabled healthcare system.
Details
- Tool name
- AI Airlock programme
- Organisation
- Medicines and Healthcare products Regulatory Agency
- Status
- live
- AI method (as recorded)
- Other, Machine Learning, generativeAI
- AI method (normalised tags)
- Other Machine Learning generativeAI
- Usecase
- Health AI
- Origin
- gov.uk
- Owning team
- Medicines and Healthcare products Regulatory Agency (MHRA)
- Date added
- 16 October 2025
- Scrape date
- Source note
- The AI Airlock programme has selected seven manufacturers developing novel AI-powered healthcare technologies for its second phase. These technologies include tools for reducing bowel cancer test times from weeks to minutes, detecting skin cancer and genetic eye diseases sooner, AI-powered clinical note taking, advanced cancer diagnostics, eye disease detection, hospital stay summaries, and blood test interpretation. [Source]